Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion type Assertion NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_head.
- NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_provenance.
- NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion evidence source_evidence_literature NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_provenance.
- NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion SIO_000772 17189383 NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_provenance.
- NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion wasDerivedFrom befree-2016 NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_provenance.
- NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion wasGeneratedBy ECO_0000203 NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_provenance.